EXPLANATORY STATEMENT
National Health Act 1953
National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2012 (No. 3)
PB 102 of 2012
Authority
Subsection 100(1) of the National Health Act 1953 (the Act) enables the Minister to make special arrangements for the supply of pharmaceutical benefits. Subsection 100(2) of the Act provides that the Minister may vary or revoke a special arrangement made under subsection 100(1).
Subsection 100(3) of the Act provides that Part VII of the Act, and instruments made for the purposes of Part VII of the Act, have effect subject to a special arrangement made under subsection 100(1).
Purpose
The National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010 (PB 65 of 2010) (the Special Arrangement), makes special arrangements for the supply of Pharmaceutical Benefits Scheme (PBS) medicines to remote Aboriginal Health Services. Section 5 of PB 65 of 2010 sets out the pharmaceutical benefits that are available under the Special Arrangement; section 9 provides for payments to approved pharmacists and approved hospital authorities who supply pharmaceutical benefits to Aboriginal Health Services under the Special Arrangement.
This Amendment Instrument inserts headings for section 5 and section 9 to reinstate the headings as they had appeared prior to being inadvertently omitted from PB 65 of 2010 by amendment instrument No. 2 of 2012 (PB 87 of 2012) which commenced on 1 October 2012.
Consultation
The changes made by this Instrument are minor and machinery in nature. No consultation was undertaken.
This Instrument commences upon registration.
This Instrument is a legislative instrument for the purposes of the Legislative Instruments Act 2003.
Statement of Compatibility with Human Rights
Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011
National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2012 (No.3)
PB 102 of 2012
This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.
Overview of the Legislative Instrument
The purpose of this Legislative Instrument, made under subsections 100(1) and 100(2) of the Act, is to amend the National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010 (PB 65 of 2010) (the Special Arrangement).
This Instrument amends PB 65 of 2010 to reinstate headings for section 5 and section 9 which were inadvertently omitted by amendment instrument No. 2 of 2012 (PB 87 of 2012) from 1 October 2012.
Human rights implications
This legislative instrument engages Articles 2 and 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR) by assisting with the progressive realisation by all appropriate means of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.
The Pharmaceutical Benefits Scheme (PBS) is a benefit scheme which assists with advancement of this human right by providing for subsidised access by patients to medicines. This Special Arrangement ensures more ready and equitable access to PBS medicines for Indigenous Australians and is part of the Australian Government’s Closing the Gap reform agenda. Closing the Gap is a commitment by all Australian governments to improve the lives of Indigenous Australians, and in particular provide a better future for Indigenous children.
Conclusion
This Legislative Instrument is compatible with human rights because it advances the protection of human rights.
Kim Bessell
Assistant Secretary
Pharmaceutical Access Branch
Principal Pharmacy Advisor
Pharmaceutical Benefits Division
Department of Health and Ageing
Overview
The National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2012 (No. 3) was enacted to correct an oversight in the National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010. This amendment was made under the authority of the National Health Act 1953, enabling the Minister to establish special arrangements for the supply of pharmaceutical benefits. The specific purpose of this 2012 amendment was to reinstate headings for sections 5 and 9 of the 2010 Instrument, which had been inadvertently omitted by a previous amendment. This correction is intended to ensure clarity and continuity in the legislative framework supporting the Remote Aboriginal Health Services Program, which aims to provide equitable access to essential medicines for Indigenous Australians, aligning with the broader Closing the Gap initiative.
Scope and Application
The National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2012 (No. 3) amends the National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010, which was established under the National Health Act 1953 to facilitate the supply of Pharmaceutical Benefits Scheme (PBS) medicines to remote Aboriginal Health Services. This amendment specifically addresses the inadvertent omission of headings for sections 5 and 9 in the 2010 Instrument, which was caused by a previous amendment instrument in 2012. The Instrument applies to authorised pharmacists and hospital authorities who supply pharmaceutical benefits under the Special Arrangement, ensuring that they are appropriately recognised and remunerated for their services. The scope of the Act is national, as it pertains to the Commonwealth's administration of the PBS and the broader health services for Indigenous Australians. The amendment does not introduce new exclusions or thresholds but ensures the correct administrative framework is in place for the Special Arrangement, thereby maintaining its integrity and effectiveness in serving remote Aboriginal Health Services.
Key Provisions
The key provisions of the National Health (Remote Aboriginal Health Services Program) Special Arrangements Amendment Instrument 2012 (No. 3) (PB 102 of 2012) focus on reinstating headings for sections 5 and 9 of the National Health (Remote Aboriginal Health Services Program) Special Arrangements Instrument 2010 (PB 65 of 2010) that were inadvertently omitted by an earlier amendment (PB 87 of 2012). Section 5 of PB 65 of 2010 pertains to the pharmaceutical benefits available under the Special Arrangement, which ensures the supply of Pharmaceutical Benefits Scheme (PBS) medicines to remote Aboriginal Health Services. Section 9 deals with payments to approved pharmacists and approved hospital authorities who supply these pharmaceutical benefits. The amendment instrument aims to correct the oversight by reinstating the original headings, ensuring clarity and proper administration of the special arrangements for the supply of PBS medicines to these services.
The obligations imposed by the Amendment Instrument on the parties involved include the accurate identification and classification of the pharmaceutical benefits under section 5 and the proper processing of payments to approved pharmacists and approved hospital authorities as outlined in section 9. This ensures that the supply chain for PBS medicines to remote Aboriginal Health Services remains transparent and efficient. The Minister retains the authority to make special arrangements for the supply of pharmaceutical benefits and to vary or revoke these arrangements as necessary, subject to the provisions of the National Health Act 1953 (section 100).
In terms of compliance, the Instrument does not introduce new offences or penalties but ensures that the existing framework remains intact and properly administered. The original Special Arrangement, as amended by PB 87 of 2012, is subject to the provisions of Part VII of the National Health Act 1953. Any breaches of the special arrangements could lead to revocation or variation of these arrangements, impacting the supply of PBS medicines to remote Aboriginal Health Services. The specific penalties for non-compliance are not detailed in the Amendment Instrument but would generally be in line with the provisions of the primary Act and any relevant regulations or guidelines.